Patents by Inventor Hemant K. Vyas

Hemant K. Vyas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant HIV epitopes and uses thereof
    Patent number: 11129889
    Abstract: Provided herein are recombinant nucleic acid sequences derived from the C-terminal domain of the HIV-1 gp41 protein, and more specifically compositions and methods for using these epitopes to develop vaccine protection against HIV. Also provided here are monoclonal antibodies that specifically bind to these recombinant nucleic acid sequences derived from the C-terminal domain of the HIV-1 gp41 protein.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: September 28, 2021
    Inventors: Ruth M. Ruprecht, Hemant K. Vyas
  • NOVEL RECOMBINANT HIV EPITOPES AND USES THEREOF
    Publication number: 20190298820
    Abstract: Provided herein are recombinant nucleic acid sequences derived from the C-terminal domain of the HIV-1 gp41 protein, and more specifically compositions and methods for using these epitopes to develop vaccine protection against HIV. Also provided here are monoclonal antibodies that specifically bind to these recombinant nucleic acid sequences derived from the C-terminal domain of the HIV-1 gp41 protein.
    Type: Application
    Filed: November 7, 2017
    Publication date: October 3, 2019
    Inventors: Ruth M. Ruprecht, Hemant K. Vyas